Biopharma sees strong Q2 2023 market cap growth
Johnson & Johnson have been shifted from the top position…
Johnson & Johnson have been shifted from the top position in the market capitalisation ranking for the first time, due to Eli Lilly having the largest growth during Q2 2023, research shows.